ASCO Future Focus: NSCLC
<ѻý class="page-description">Future Focus from the American Society of Clinical Oncologyѻý>Patients by far prefer subcutaneous to intravenous medication delivery, says Jorge Nieva, MD
August 6, 2024
Streamlined approach broadens eligibility and reduces site burden
July 30, 2024
And minimal residual disease analysis may help determine length of therapy
July 23, 2024
<ѻý class="section_title"> Latest Oncology/Hematology Meeting Coverageѻý>
-
ASTRO: American Society for Radiation Oncology
September 2024
-
ESMO: European Society for Medical Oncology
September 2024
-
ASCO: American Society of Clinical Oncology
May 2024
-
AACR: American Association for Cancer Research
April 2024